Nida center for genetic studies. March 14, 2026 - march 13, 2027. N01DA-23-7787. Task order 75N95026F00001 (TO4).
Active Awarded Last action
- Contract number
- 75N95026F00001
- Awardee
-
Infinity Biologix LLC UEI NPUACRBK7TV9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,957,934
Award facts
- Contract value 100% obligated
- $2,957,934.00 Current and potential, with all options
- Completion date 62% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $2.96 million to Infinity Biologix LLC for continued operation of the NIDA Center for Genetic Studies. This task order (75N95026F00001, designated TO4) runs from March 14, 2026 through March 13, 2027 and represents work performed at the contractor's facility in Piscataway, New Jersey. The award utilizes a firm-fixed-price contract structure with no socioeconomic set-aside and is part of a larger $15 million indefinite delivery contract that Infinity Biologix maintains with NIDA for genetic studies services. The delivery order falls under NIDA's genetic research initiatives, which support the agency's mission to advance understanding of substance use disorders through genomic analysis and biospecimen research.
Infinity Biologix LLC, a for-profit limited liability company specializing in advanced genomic analysis and biorepository solutions, is well-positioned to execute this work given its established track record with federal research agencies. The company has demonstrated substantial capacity across multiple scientific domains, including genome characterization, next-generation sequencing, and biospecimen processing for agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans Affairs. This delivery order builds on the contractor's existing IDC with NIDA and reflects the company's recognized expertise in providing high-complexity laboratory and genomic research services critical to federal scientific initiatives.
Quick answers
Who was awarded contract 75N95026F00001?
75N95026F00001 was awarded to Infinity Biologix LLC by National Institute on Drug Abuse (National Institutes of Health) on March 14, 2026.
How much is contract 75N95026F00001 worth?
The government has obligated $2,957,934 on 75N95026F00001.
Is contract 75N95026F00001 an order under another contract?
Yes. 75N95026F00001 is a delivery order under 75N95025D00005, an indefinite delivery contract.
Was contract 75N95026F00001 competed?
The extent of competition for 75N95026F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award